For example, deguelin can suppress tumor angiogenesis on vascular endothelial cells by decreasing autocrine VEGF and repressing HGF-induced c-Met signaling pathways, thereby inhibiting HCC progression (Li et al., 2018). This evidence concerns the gene MET and hepatocellular carcinoma.